Predicate Devices

Reference Devices

Not Found

AI/ML (Artificial Intelligence / Machine Learning)

No
The summary describes a mechanical embolic protection system and does not mention any AI or ML components or functionalities.

Therapeutic

Yes
The device is used to capture and remove embolic material, which is a therapeutic intervention aimed at treating a medical condition (embolic events during percutaneous transluminal interventional procedures).

Diagnostic

No

The device is designed to capture and remove embolic material, meaning it is used for treatment and not for diagnosing a condition.

SaMD (Software as a Medical Device)

No

The device description clearly outlines physical components such as a guidewire, fiber filter, actuator tool, aspiration catheter, syringes, introducer, and cell strainer cup. This indicates it is a hardware-based medical device, not software-only.

IVD (In Vitro Diagnostic)

Based on the provided information, the FiberNet® Embolic Protection System is not an IVD (In Vitro Diagnostic).

Here's why:

Intended Use: The intended use clearly describes a device used within the body during a surgical procedure (percutaneous transluminal interventional procedures in carotid arteries). IVDs are used to examine specimens outside the body (in vitro) to provide information about a patient's health.
Device Description: The components listed (guidewire, filter, aspiration catheter, syringes, introducer) are all consistent with devices used for interventional procedures within the body.
Anatomical Site: The device is used in the carotid arteries, which are internal to the body.
Performance Studies: The performance studies described (bench tests like wall integrity, push/track, stent crossing, and biocompatibility tests) are typical for medical devices used in vivo, not for IVDs which would focus on analytical performance with biological samples.

Therefore, the FiberNet® Embolic Protection System is a medical device used for an interventional procedure, not an in vitro diagnostic device.

PCCP (Predetermined Change Control Plan) Authorized

N/A

Overview

Intended Use / Indications for Use

The FiberNet® Embolic Protection System is indicated for use as a guidewire and emboli protection system to capture and remove embolic material (thrombus/debris) produced while performing percutaneous transluminal interventional procedures in carotid arteries in high surgical risk patients with reference vessel diameters of 3.5 to 7.0 mm.

Product codes (comma separated list FDA assigned to the subject device)

NTE

Device Description

The FiberNet Embolic Protection System consists of a fiber filter on a 0.014" guide wire with attachable actuator tool and a 0.014" guidewire compatible aspiration catheter with attachable stopcock assembly. System accessories included in the package consist of two 30 ml syringes, a peel-away introducer and a 40µm cell strainer cup.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

carotid arteries

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Bench tests performed included:

Wall integrity/aspiration rate
. Push/track
. Stent crossing
. Torque response
Tip stiffness
Torque strength
Liquid leakage under aspiration
Liquid leakage pressure hub/catheter
. Kink resistance
Tensile bonds and joints (catheter port and hub) .
Device retraction .

Biocompatibility was supported by material manufacturer data and the following additional tests:

. Cytotoxicity
Hemolysis (direct and extract)
Complement Activation .
. Unactivated Partial Thromboplastin Time Assay (direct and indirect)
. In vivo Thrombogenicity
Physical Chemical .

The results of the in vitro bench and biocompatibility testing demonstrated the system is equivalent to the predicate device.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K082348

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

Regulation Number and Section

§ 870.1250 Percutaneous catheter.

(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).

Summary

0

Image /page/0/Picture/1 description: The image shows the words "LUMEN BIOMEDICAL" stacked on top of each other. The word "LUMEN" is on the top line, and the word "BIOMEDICAL" is on the bottom line. The text is black and has a rough, textured appearance. There are also some white lines going through the word "LUMEN".

AUG 177 2011

Lumen Biomedical, Inc.

10900 731d Avenue North, Suite 150 Maple Grove, MN 55369 (763) 577-9600 Business
(763) 557-1044 Fax

510(k) Summary

| Contact Person: | Michelle Straight
Director of Quality Assurance and Regulatory Affairs |
|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Summary Date: | July 12, 2011 |
| Product Trade Name: | FiberNet® Embolic Protection System |
| Common Name: | Embolic Protection Device |
| Classification Name: | Catheter, Percutaneous |
| Predicate(s): | FiberNet Embolic Protection System (K082348) |
| Intended Use: | The FiberNet® Embolic Protection System is indicated for use as a
guidewire and emboli protection system to capture and remove embolic
material (thrombus/debris) produced while performing percutaneous
transluminal interventional procedures in carotid arteries in high surgical
risk patients with reference vessel diameters of 3.5 to 7.0 mm. |
| Device Description: | The FiberNet Embolic Protection System consists of a fiber filter on a
0.014" guide wire with attachable actuator tool and a 0.014" guidewire
compatible aspiration catheter with attachable stopcock assembly.
System accessories included in the package consist of two 30 ml
syringes, a peel-away introducer and a 40µm cell strainer cup. |
| Indication for Use: | The FiberNet Embolic Protection System is indicated for use as a
guidewire and emboli protection system to capture and remove embolic
material (thrombus/debris) produced while performing percutaneous
transluminal interventional procedures in carotid arteries in high surgical
risk patients with reference vessel diameters of 3.5 to 7.0 mm. |
| Technological
Characteristics | The FiberNet Embolic Protection System has the same technological
characteristics as the predicate device except for the following:
• Addition of antioxidants to the catheter material
• Addition of a white colorant near the RX port
• Change in the distal liner material to a material used in the mid
shaft of the catheter
• Increase in the proximal shaft OD |

1

The results of the in vitro bench and biocompatibility testing demonstrated the system is equivalent to the predicate device.

Bench tests performed included:

Wall integrity/aspiration rate ●
. Push/track
. Stent crossing
. Torque response
Tip stiffness
� Torque strength
Liquid leakage under aspiration
Liquid leakage pressure hub/catheter ●

Safety & Performance:

. Kink resistance
Tensile bonds and joints (catheter port and hub) .
Device retraction ●

Biocompatibility was supported by material manufacturer data and the following additional tests:

. Cytotoxicity
Hemolysis (direct and extract) ◆
Complement Activation .
. Unactivated Partial Thromboplastin Time Assay (direct and indirect)
. In vivo Thrombogenicity
Physical Chemical .

Conclusion:

This product is substantially equivalent and acceptable for the intended use.

l This document uses the term "substantial equivalent" as intended in 21 CFR 807.87 and not as defined in Title 36 of the U.S. Code.

2

Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo features a stylized eagle with three curved lines representing its wings. The eagle is positioned to the right of the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA", which is arranged in a circular fashion around the eagle.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Michelle Straight Director of Quality Assurance and Regulatory Affairs Lumen Biomedical, Inc. 10900 73rd Ave. N. Suite 150 Maple Grove, MN 55369

AUG 1 7 2011

Re: K111987

Trade/Device Name: Fibernet Embolic Protection System Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: NTE Dated: July 12, 2011 Received: July 13, 2011

Dear Ms. Straight:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act

3

Page 2 - Ms. Michelle Straight

or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803): good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.html for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Bram Zuckerman

r Bram Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Indications for Use

510(k) Number (if known): K1) 1987

FiberNet® Embolic Protection System Device Name:

Indications for Use:

The FiberNet® Embolic Protection System is indicated for use as a guidewire and emboli protection system to capture and remove embolic material (thrombus/debris) produced while performing percutaneous transluminal interventional procedures in carotid arteries in high surgical risk patients with reference vessel diameters of 3.5 to 7.0 mm.

Prescription Use X AND/OR (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

_
(Division Sign-Off)

Division of Cardiovascular Devices

510(k) Number K111987

Confidential

Lumen Biomedical, Inc.